Sight Diagnostics news
Israel’s Sight Diagnostics, a startup that analyzes blood samples with a small device in minutes, has inked a deal to install its products in the United Arab Emirates and other Gulf countries.
The company said on Wednesday it had agreed to a distribution partnership with the Dubai-based business development firm Phoenix Capital.
Sight will provide its OLO blood analyzer machines to nine medical centers owned by Phoenix in the
Israel’s Sight Diagnostics said on Wednesday it raised $71 million in private funding to expand sales of its finger-prick blood analyzer and support research and development. Koch Disruptive Technologies, Longliv Ventures, which is part of the CK Hutchison Group, and Israel’s OurCrowd participated in the round, which brings Sight’s total funding to more than $124 million.
Read more
Israeli blood testing startup S.D. Sight Diagnostics Ltd. has raised $71 million from international venture capital funds and U.S. corporations, Clal Biotechnology Industries Ltd. revealed in a report sent to the Tel Aviv Stock Exchange last week. Sight Diagnostics has yet to announce the details of the new funding round, but Clal Biotechnology Industries stated in its report that following the news its Anatomy Technology Fund, of which it holds a 50% stake, now owns 4% of Sight Diagnos